Profiles Sx - Selected Cancer Screening and MCED

Non-invasive and disruptive Evidence Based Laboratory Medicine (EBLM) tests that are designed for the screening and detection of cancer, even in its early stages.

All Venient Sx screening tests are exclusively based on routine blood and urine tests, which powered by our own Machine Learning algorithms (ML), provide unprecedented rates of accuracy.

These tests are focused in the detection of cancer in asymptomatic patients, even in the initial stages, before symptoms appear and when treatment is most likely to be successful. They are also based in the Barcelona Criteria, which were proposed by the Spanish Society of Laboratory Medicine (SEQC^ML) in 1994 and further reviewed in 2024, for the correct interpretation of serum tumor markers (TM) in order to detect and avoid false positive (FP) results.